Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

This month, the White House released a statement that confirmed Trump “underwent a comprehensive examination” that revealed he had chronic venous insufficiency. Here's what that means, according to ...

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

Congress removed from a list of programmes from which the Trump administration wants to cut funds, doesn’t cancel the cuts to ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

This fresh warning follows the release of the 2025 Global Aids Update report by the Joint United Nations Programme on HIV/Aids (UNAIDS), which shows that 36,648 new HIV infections were ...

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are ...